Lili Yang

9PUBLICATIONS
2CO-AUTHORS
Molecular targetsInnate immunityEpigenetics (incl. genome methylation and epigenomics)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 05, 2026
RanBP2 promotes ferroptosis resistance and compromises therapeutic response by stabilizing SLC7A1 through LRSAM1 SUMOylation and ubiquitination in lung adenocarcinoma.

|Jun 02, 2026
Low expression of ONECUT2 governs the POU6F2-beta-catenin axis to modulate cancer stemness and drives the CCL28-dependent pathway for macrophage polarization in breast cancer.

|Apr 25, 2025
scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer.

Ziqi Huang, Li Li, Xiaohe Zhao

|Dec 10, 2023
Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma.

Ziqi Huang, Yan Guo, Baihui Li

|Oct 04, 2023
HMGB1/SET/HAT1 complex-mediated SASH1 repression drives glycolysis and metastasis in lung adenocarcinoma.

Fan Kou, Lei Wu, Yu Zheng

|Sep 06, 2023
Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas.

Baihui Li, Yan Guo, Yeran Yi

Pageof 2

Frequent Collaborators

3 joint publications

Xiubao Ren

2 joint publications

Ziqi Huang